Correction to “New Potent RIPK2 Inhibitors as a Promising Therapeutic Avenue for Colitis Through the Blockade of NOD Inflammatory Pathways”

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medicinal chemistry 2024-12, Vol.67 (24), p.22343-22343
Hauptverfasser:	Rivoal, Morgane, Barczyk, Amélie, Six, Perrine, Dezitter, Xavier, Cornu-Choi, Min-Jeong, Body-Malapel, Mathilde, Djouina, Madjid, Waxin, Christophe, Dubuquoy, Laurent, Millet, Régis, Leleu-Chavain, Natascha
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	22343
container_issue	24
container_start_page	22343
container_title	Journal of medicinal chemistry
container_volume	67
creator	Rivoal, Morgane Barczyk, Amélie Six, Perrine Dezitter, Xavier Cornu-Choi, Min-Jeong Body-Malapel, Mathilde Djouina, Madjid Waxin, Christophe Dubuquoy, Laurent Millet, Régis Leleu-Chavain, Natascha
description
doi_str_mv	10.1021/acs.jmedchem.4c02770
format	Article
fullrecord	<record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_acs_jmedchem_4c02770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a868924556</sourcerecordid><originalsourceid>FETCH-LOGICAL-a1320-9db58ccfa749b156d1c22e8c5f57b145ac4d6559da66917beae5b5dc657a5cfc3</originalsourceid><addsrcrecordid>eNp9kE1OwzAQRi0EEqVwAxa-QIrtxEmzLOGvomojVNaR49iNSxJXtkvVXW_ABeByPQmGli3SSLP49D7NPACuMRpgRPAN43awbEXFa9EOIo5IkqAT0MOUoCAaougU9BAiJCAxCc_BhbVLhFCISdgDH5k2RnCndAedhvvd51RsYK6d6Bx8GefPBI67WpXKaWMh8wNzo1tlVbeA81oYthJrpzgcvYtuLaDUBma6UU5ZHxu9XtTQ1QLeNpq_sUpALeF0dudLZcPalvnaLcyZqzdsa_e7r0twJlljxdVx98Hrw_08ewoms8dxNpoEDIf-q7Qq6ZBzyZIoLTGNK8wJEUNOJU1KHFHGoyqmNK1YHKc4KQUTtKQVj2nCKJc87IPo0MuNttYIWayMapnZFhgVP1ILL7X4k1ocpXoMHbDfVK9N54_8H_kGNimC5w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Correction to “New Potent RIPK2 Inhibitors as a Promising Therapeutic Avenue for Colitis Through the Blockade of NOD Inflammatory Pathways”</title><source>American Chemical Society Journals</source><creator>Rivoal, Morgane ; Barczyk, Amélie ; Six, Perrine ; Dezitter, Xavier ; Cornu-Choi, Min-Jeong ; Body-Malapel, Mathilde ; Djouina, Madjid ; Waxin, Christophe ; Dubuquoy, Laurent ; Millet, Régis ; Leleu-Chavain, Natascha</creator><creatorcontrib>Rivoal, Morgane ; Barczyk, Amélie ; Six, Perrine ; Dezitter, Xavier ; Cornu-Choi, Min-Jeong ; Body-Malapel, Mathilde ; Djouina, Madjid ; Waxin, Christophe ; Dubuquoy, Laurent ; Millet, Régis ; Leleu-Chavain, Natascha</creatorcontrib><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.4c02770</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2024-12, Vol.67 (24), p.22343-22343</ispartof><rights>2024 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a1320-9db58ccfa749b156d1c22e8c5f57b145ac4d6559da66917beae5b5dc657a5cfc3</cites><orcidid>0000-0003-3392-4229 ; 0000-0001-6932-6947 ; 0000-0002-3904-4815 ; 0000-0003-3596-5497</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c02770$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02770$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2763,27074,27922,27923,56736,56786</link.rule.ids></links><search><creatorcontrib>Rivoal, Morgane</creatorcontrib><creatorcontrib>Barczyk, Amélie</creatorcontrib><creatorcontrib>Six, Perrine</creatorcontrib><creatorcontrib>Dezitter, Xavier</creatorcontrib><creatorcontrib>Cornu-Choi, Min-Jeong</creatorcontrib><creatorcontrib>Body-Malapel, Mathilde</creatorcontrib><creatorcontrib>Djouina, Madjid</creatorcontrib><creatorcontrib>Waxin, Christophe</creatorcontrib><creatorcontrib>Dubuquoy, Laurent</creatorcontrib><creatorcontrib>Millet, Régis</creatorcontrib><creatorcontrib>Leleu-Chavain, Natascha</creatorcontrib><title>Correction to “New Potent RIPK2 Inhibitors as a Promising Therapeutic Avenue for Colitis Through the Blockade of NOD Inflammatory Pathways”</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1OwzAQRi0EEqVwAxa-QIrtxEmzLOGvomojVNaR49iNSxJXtkvVXW_ABeByPQmGli3SSLP49D7NPACuMRpgRPAN43awbEXFa9EOIo5IkqAT0MOUoCAaougU9BAiJCAxCc_BhbVLhFCISdgDH5k2RnCndAedhvvd51RsYK6d6Bx8GefPBI67WpXKaWMh8wNzo1tlVbeA81oYthJrpzgcvYtuLaDUBma6UU5ZHxu9XtTQ1QLeNpq_sUpALeF0dudLZcPalvnaLcyZqzdsa_e7r0twJlljxdVx98Hrw_08ewoms8dxNpoEDIf-q7Qq6ZBzyZIoLTGNK8wJEUNOJU1KHFHGoyqmNK1YHKc4KQUTtKQVj2nCKJc87IPo0MuNttYIWayMapnZFhgVP1ILL7X4k1ocpXoMHbDfVK9N54_8H_kGNimC5w</recordid><startdate>20241226</startdate><enddate>20241226</enddate><creator>Rivoal, Morgane</creator><creator>Barczyk, Amélie</creator><creator>Six, Perrine</creator><creator>Dezitter, Xavier</creator><creator>Cornu-Choi, Min-Jeong</creator><creator>Body-Malapel, Mathilde</creator><creator>Djouina, Madjid</creator><creator>Waxin, Christophe</creator><creator>Dubuquoy, Laurent</creator><creator>Millet, Régis</creator><creator>Leleu-Chavain, Natascha</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-3392-4229</orcidid><orcidid>https://orcid.org/0000-0001-6932-6947</orcidid><orcidid>https://orcid.org/0000-0002-3904-4815</orcidid><orcidid>https://orcid.org/0000-0003-3596-5497</orcidid></search><sort><creationdate>20241226</creationdate><title>Correction to “New Potent RIPK2 Inhibitors as a Promising Therapeutic Avenue for Colitis Through the Blockade of NOD Inflammatory Pathways”</title><author>Rivoal, Morgane ; Barczyk, Amélie ; Six, Perrine ; Dezitter, Xavier ; Cornu-Choi, Min-Jeong ; Body-Malapel, Mathilde ; Djouina, Madjid ; Waxin, Christophe ; Dubuquoy, Laurent ; Millet, Régis ; Leleu-Chavain, Natascha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a1320-9db58ccfa749b156d1c22e8c5f57b145ac4d6559da66917beae5b5dc657a5cfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rivoal, Morgane</creatorcontrib><creatorcontrib>Barczyk, Amélie</creatorcontrib><creatorcontrib>Six, Perrine</creatorcontrib><creatorcontrib>Dezitter, Xavier</creatorcontrib><creatorcontrib>Cornu-Choi, Min-Jeong</creatorcontrib><creatorcontrib>Body-Malapel, Mathilde</creatorcontrib><creatorcontrib>Djouina, Madjid</creatorcontrib><creatorcontrib>Waxin, Christophe</creatorcontrib><creatorcontrib>Dubuquoy, Laurent</creatorcontrib><creatorcontrib>Millet, Régis</creatorcontrib><creatorcontrib>Leleu-Chavain, Natascha</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivoal, Morgane</au><au>Barczyk, Amélie</au><au>Six, Perrine</au><au>Dezitter, Xavier</au><au>Cornu-Choi, Min-Jeong</au><au>Body-Malapel, Mathilde</au><au>Djouina, Madjid</au><au>Waxin, Christophe</au><au>Dubuquoy, Laurent</au><au>Millet, Régis</au><au>Leleu-Chavain, Natascha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to “New Potent RIPK2 Inhibitors as a Promising Therapeutic Avenue for Colitis Through the Blockade of NOD Inflammatory Pathways”</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2024-12-26</date><risdate>2024</risdate><volume>67</volume><issue>24</issue><spage>22343</spage><epage>22343</epage><pages>22343-22343</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><pub>American Chemical Society</pub><doi>10.1021/acs.jmedchem.4c02770</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3392-4229</orcidid><orcidid>https://orcid.org/0000-0001-6932-6947</orcidid><orcidid>https://orcid.org/0000-0002-3904-4815</orcidid><orcidid>https://orcid.org/0000-0003-3596-5497</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0022-2623
ispartof	Journal of medicinal chemistry, 2024-12, Vol.67 (24), p.22343-22343
issn	0022-2623 1520-4804
language	eng
recordid	cdi_crossref_primary_10_1021_acs_jmedchem_4c02770
source	American Chemical Society Journals
title	Correction to “New Potent RIPK2 Inhibitors as a Promising Therapeutic Avenue for Colitis Through the Blockade of NOD Inflammatory Pathways”
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T08%3A41%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to%20%E2%80%9CNew%20Potent%20RIPK2%20Inhibitors%20as%20a%20Promising%20Therapeutic%20Avenue%20for%20Colitis%20Through%20the%20Blockade%20of%20NOD%20Inflammatory%20Pathways%E2%80%9D&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Rivoal,%20Morgane&rft.date=2024-12-26&rft.volume=67&rft.issue=24&rft.spage=22343&rft.epage=22343&rft.pages=22343-22343&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.4c02770&rft_dat=%3Cacs_cross%3Ea868924556%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true